vs
Side-by-side financial comparison of Entrada Therapeutics, Inc. (TRDA) and Village Farms International, Inc. (VFF). Click either name above to swap in a different company.
Entrada Therapeutics, Inc. is the larger business by last-quarter revenue ($20.6M vs $12.2M, roughly 1.7× Village Farms International, Inc.). Village Farms International, Inc. runs the higher net margin — 19.9% vs -84.4%, a 104.3% gap on every dollar of revenue. On growth, Village Farms International, Inc. posted the faster year-over-year revenue change (31.5% vs -65.2%).
Entrada Therapeutics is a clinical-stage biotechnology firm developing transformative intracellular therapies for serious rare diseases and high-unmet-need disorders. Its pipeline covers neuromuscular, metabolic, and central nervous system segments, serving global patients via healthcare partnerships.
Grafton Village Cheese Company is a cheesemaker in the town of Grafton in the U.S. state of Vermont. The company produces hand-crafted aged cheddar cheese.
TRDA vs VFF — Head-to-Head
Income Statement — Q1 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $20.6M | $12.2M |
| Net Profit | $-17.3M | $2.4M |
| Gross Margin | — | — |
| Operating Margin | -106.0% | — |
| Net Margin | -84.4% | 19.9% |
| Revenue YoY | -65.2% | 31.5% |
| Net Profit YoY | -173.8% | 128.2% |
| EPS (diluted) | $-0.42 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $12.2M | ||
| Q3 25 | — | $66.7M | ||
| Q2 25 | — | $59.9M | ||
| Q1 25 | $20.6M | $77.1M | ||
| Q4 24 | $37.4M | — | ||
| Q3 24 | $19.6M | $54.9M | ||
| Q2 24 | $94.7M | $53.6M | ||
| Q1 24 | $59.1M | $78.1M |
| Q4 25 | — | $2.4M | ||
| Q3 25 | — | $10.2M | ||
| Q2 25 | — | $26.5M | ||
| Q1 25 | $-17.3M | $-6.7M | ||
| Q4 24 | $1.1M | — | ||
| Q3 24 | $-14.0M | $-820.0K | ||
| Q2 24 | $55.0M | $-23.5M | ||
| Q1 24 | $23.5M | $-2.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | 47.9% | ||
| Q2 25 | — | 37.3% | ||
| Q1 25 | — | 14.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 24.8% | ||
| Q2 24 | — | 25.4% | ||
| Q1 24 | — | 19.9% |
| Q4 25 | — | — | ||
| Q3 25 | — | 23.3% | ||
| Q2 25 | — | 20.8% | ||
| Q1 25 | -106.0% | -8.0% | ||
| Q4 24 | -15.7% | — | ||
| Q3 24 | -110.7% | 3.8% | ||
| Q2 24 | 56.4% | -43.5% | ||
| Q1 24 | 35.7% | -3.0% |
| Q4 25 | — | 19.9% | ||
| Q3 25 | — | 15.3% | ||
| Q2 25 | — | 44.2% | ||
| Q1 25 | -84.4% | -8.7% | ||
| Q4 24 | 3.0% | — | ||
| Q3 24 | -71.7% | -1.5% | ||
| Q2 24 | 58.1% | -43.9% | ||
| Q1 24 | 39.7% | -3.7% |
| Q4 25 | — | $0.01 | ||
| Q3 25 | — | $0.08 | ||
| Q2 25 | — | $0.24 | ||
| Q1 25 | $-0.42 | $-0.06 | ||
| Q4 24 | $-0.20 | — | ||
| Q3 24 | $-0.35 | $-0.01 | ||
| Q2 24 | $1.55 | $-0.21 | ||
| Q1 24 | $0.68 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $67.8M | $81.2M |
| Total DebtLower is stronger | — | $33.7M |
| Stockholders' EquityBook value | $417.3M | $299.9M |
| Total Assets | $486.5M | $423.1M |
| Debt / EquityLower = less leverage | — | 0.11× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $81.2M | ||
| Q3 25 | — | $82.6M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | $67.8M | $15.1M | ||
| Q4 24 | $101.2M | — | ||
| Q3 24 | $78.0M | $28.7M | ||
| Q2 24 | $185.3M | $29.7M | ||
| Q1 24 | $68.4M | $26.7M |
| Q4 25 | — | $33.7M | ||
| Q3 25 | — | $34.6M | ||
| Q2 25 | — | $39.1M | ||
| Q1 25 | — | $39.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $43.3M | ||
| Q2 24 | — | $44.4M | ||
| Q1 24 | — | $46.1M |
| Q4 25 | — | $299.9M | ||
| Q3 25 | — | $295.4M | ||
| Q2 25 | — | $284.3M | ||
| Q1 25 | $417.3M | $248.3M | ||
| Q4 24 | $428.7M | — | ||
| Q3 24 | $422.4M | $274.4M | ||
| Q2 24 | $429.9M | $275.2M | ||
| Q1 24 | $269.4M | $296.2M |
| Q4 25 | — | $423.1M | ||
| Q3 25 | — | $418.4M | ||
| Q2 25 | — | $403.7M | ||
| Q1 25 | $486.5M | $377.1M | ||
| Q4 24 | $526.3M | — | ||
| Q3 24 | $554.6M | $417.8M | ||
| Q2 24 | $582.0M | $425.4M | ||
| Q1 24 | $510.8M | $458.4M |
| Q4 25 | — | 0.11× | ||
| Q3 25 | — | 0.12× | ||
| Q2 25 | — | 0.14× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.16× | ||
| Q2 24 | — | 0.16× | ||
| Q1 24 | — | 0.16× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-38.5M | — |
| Free Cash FlowOCF − Capex | $-39.7M | — |
| FCF MarginFCF / Revenue | -192.9% | — |
| Capex IntensityCapex / Revenue | 5.6% | 90.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-58.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | $24.4M | ||
| Q2 25 | — | — | ||
| Q1 25 | $-38.5M | $-6.4M | ||
| Q4 24 | $-31.6M | — | ||
| Q3 24 | $-24.3M | $4.3M | ||
| Q2 24 | $39.8M | $5.7M | ||
| Q1 24 | $-25.5M | $-50.0K |
| Q4 25 | — | — | ||
| Q3 25 | — | $22.6M | ||
| Q2 25 | — | — | ||
| Q1 25 | $-39.7M | $-8.9M | ||
| Q4 24 | $-32.2M | — | ||
| Q3 24 | $-24.9M | $1.5M | ||
| Q2 24 | $38.8M | $4.8M | ||
| Q1 24 | $-26.4M | $-1.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | 33.9% | ||
| Q2 25 | — | — | ||
| Q1 25 | -192.9% | -11.6% | ||
| Q4 24 | -86.2% | — | ||
| Q3 24 | -127.3% | 2.7% | ||
| Q2 24 | 41.0% | 9.0% | ||
| Q1 24 | -44.6% | -2.5% |
| Q4 25 | — | 90.8% | ||
| Q3 25 | — | 2.7% | ||
| Q2 25 | — | 4.6% | ||
| Q1 25 | 5.6% | 3.3% | ||
| Q4 24 | 1.7% | — | ||
| Q3 24 | 3.3% | 5.1% | ||
| Q2 24 | 1.1% | 1.6% | ||
| Q1 24 | 1.4% | 2.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | 2.39× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -27.94× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.72× | — | ||
| Q1 24 | -1.09× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
TRDA
Segment breakdown not available.
VFF
| International Sales | $8.7M | 71% |
| Cannabis United States Segment | $3.4M | 27% |
